PT | EN Home > FAQ

Frequently Asked Questions

 

1. What is the meaning of the word RESOLVE?
2. What is the aim of the RESOLVE Program?
3. What is the RESOLVE Toolbox?
4. How will the support by the RESOLVE Program be provided?
5. What are the eligibility criteria?
6. How do I apply to the RESOLVE Program?
7. Does the RESOLVE Program have fees for application and support?
8. When will the results of the selection process be announced?
9. Who is the jury committee?
10. What are the project evaluation criteria?
11. How will the selection results be communicated?
12. What are my duties and responsibilities as a selected participant?
13. Is confidentially of my results guaranteed?
14. How does the RESOLVE Program view intellectual property?
15. What is the process of awarding RESOLVE prizes?
16. What will be the amount of the prizes?
17. What is the RESOLVE revenue of my invention?
18. Where is the RESOLVE Program hosted? 19. How can I contact the RESOLVE Program for additional information?

 

 

 

1. What is the meaning of the word RESOLVE?

The word RESOLVE means in the Portuguese language 'to find a solution for a problem'; on the other hand, in english it also means "determination to carry out an action" - and is the acronym of this program: Respostas Específicas para Superar Obstáculos que Limitam a Valorização Eficaz.

 

2.  What is the aim of the RESOLVE Program?

The objective of the Program is to foster the transfer of knowledge, providing solutions and management tools to early stage projects and start-ups in the health sector for the transformation of innovative knowledge into business ventures and value creation.

 

3. What is the RESOLVE Toolbox?

The RESOLVE Toolbox is a set of tools designed to support selected teams to achieve their valorisation goals in a shorter timeline. The Toolbox was conceived to tackle common obstacles to the creation of value from knowledge, specifically in the health sector. These innovative tools are provided to applicants according to the diagnostic report prepared as a result of the selection process. See RESOLVE Toolbox.

 

4. How will the support by the RESOLVE Program be provided?

The support provided by the RESOLVE Program will be implemented through coaching, mentoring, project management and through the application of the RESOLVE Toolbox by the RESOLVE Team based at i3S. The Program commits to support the selected projects in the timeframe of a maximum of 12 months from the date of selection.

 

5. What are the eligibility criteria?

The RESOLVE Program will accept applications from researchers, entrepreneurs, R&D projects, technologies, seed projects or start-ups in the health sector, based or to be based in the Northern Region of Portugal (NUTS II). Applications can be submitted by an individual researcher or a team of researchers from universities, R&D institutions or start-ups, either autonomously or in consortium. The projects must have a Technology Level of Readiness (TRL) between 3 and 5 at the moment of submission. Eligible start-ups will be innovative companies looking for repeatable and scalable business models in the health sector, with no more than 3 years after legal registration.

 

6.  How do I apply to the RESOLVE Program?

The submission of projects is performed through the Application Form available at Applications.

 

7.  Are there any fees?

No fees are requested to apply or to be supported by RESOLVE Program.

 

8.  When will the results of the application process be announced?

The Program will be open continuously and will have two periods of evaluation. The first period of selection will close on the 2nd November 2016, and the second will take place in April 2017 (date to be confirmed). Between the 2nd and 15th of November the submission is closed. The evaluation process will involve two phases - Phase 1: based on the information provided in the application form, and Phase 2: based on a pitch and an interview. 

 

9. Who is the jury committee?

The applications will be evaluated by a multidisciplinary jury, including the RESOLVE Team and experts gathering academic, clinical and business perspectives (national and international).

 

10.  What are the project evaluation criteria?

The project evaluation will be based on the following criteria:

a. Scientific, technological and clinical potential;

b. Correspondence to unmet clinical needs;

c. Status of intellectual property protection;

d. Maturity of the technology;

e. Need to carry out validation and proofs of concept.

 

11. How will the selection results be communicated?

Final decisions will be communicated electronically in written form to all applicants. Irrespectively of being selected by the RESOLVE Program, all participants will receive a diagnostic report, thus increasing their chance of future success. Selected projects will be formally accepted in the RESOLVE Program upon signature of a written agreement. Failure to sign this agreement within ten (10) working days will lead to the automatically exclusion of the Program.

 

12.  What are my duties and responsibilities as a selected participant?

Participants are required to collaborate with the RESOLVE Program, specifically by communicating all relevant activities and developments regarding their participation in the Program. Selected participants agree to match, to the best of their ability, the RESOLVE Program requests. The responsibilities of the participants may include providing information, technical input, complying with agreed deliverables and deadlines, attending to meetings with project Mentors, integrating MBA students (where relevant) and being available for any presentations required by the RESOLVE Team. Failure to respond to any official requests by the RESOLVE Team may lead to exclusion, including the provision of any additional support activities or funding. For more details, see Rules and Regulations.

 

13. Does the Program ensure the confidentially of my results?

Yes. All technological and scientific information provided to the RESOLVE Program shall be treated with stringent confidentiality. The RESOLVE Team and each participant agree that the information will be exclusively used for (i) evaluation of participant’s proposal, (ii) general market analysis purposes and (iii) follow-up activities. The responsibility of the information and data is of the sole responsibility of the applicants. 

 

14. How does the RESOLVE Program view intellectual property?

The intellectual property rights concerning project applications belong to the respective(s) owner(s) at the time of application.

 

15.  What is the process of awarding RESOLVE prizes?

Only the projects selected in Phase 2 are eligible to the RESOLVE prizes. Two types of prizes will be awarded: one for the Best Innovation Project (best Researcher(s)/Start-up Team) and one for the Best Business Case (best MBA Team), for each round of applications. A jury national and international experts will select the prizes on the basis of a report to be submitted by each team and a final presentation to the jury. The prizes will be awarded 12 months after the selection to the RESOLVE Program.

 

16.  What will be the value of the prizes?

The amount of the prizes to be awarded will consist of 5000€/each: one for the Best Innovation Project (best Researcher(s)/Start-up Team) and one for the Best Business Case (best MBA Team).

 

17. What happens if I have applied to funding or support by another source?

All applications are welcome. The Program wil not offer the Tool "Validation of Prototypes and Proofs-of-Concept" which at the time of submission are already being funded by other sources to support the validation of the same object/project of the application submitted to RESOLVE. However, candidates can still apply for support by other RESOLVE Tools.

 

18. Where is the RESOLVE Program hosted?

The RESOLVE Program is based at the i3S - Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Rua Alfredo Allen, 208, 4200-135 Porto, (www.resolve-health.pt), at the Technology Transfer and Programmes Unit (TTPU).

 

19.  How can I contact the RESOLVE Program for additional information?

For any clarifications please contact to the following email resolve@i3s.up.pt